Atea Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $328k | 108k | 3.05 |
| 2023-09-30 | $171k | 57k | 3.00 |
| 2023-06-30 | $370k | 99k | 3.74 |
| 2023-03-31 | $177k | 53k | 3.35 |
| 2022-12-31 | $362k | 75k | 4.81 |
| 2022-09-30 | $89k | 15k | 5.76 |
| 2022-06-30 | $83k | 11k | 7.40 |
| 2022-03-31 | $207k | 29k | 7.13 |
| 2021-12-31 | $934k | 105k | 8.92 |
| 2021-09-30 | $2.2M | 64k | 35.06 |
| 2021-06-30 | $15M | 675k | 21.48 |
| 2021-03-31 | $224k | 3.6k | 61.78 |
| 2020-12-31 | $441k | 11k | 41.75 |